EGAGenomicsCancer Genomicshttps://ega-archive.org/studies/EGAS00001002649EGAEGA study EGAS00001002649Single cell analysis of human lung parenchymaEGArestrictedpulmones., lungs pair, Lungs, assay, set of lungs, lungs, determination, Cell, chemical analysisCG34403, l(4)13, Polyarteritis Nodosa, PhrB photolyase activity, Periarteritis Nodosa, LEF/TCF-1, hematopoietic progenitor cell antigen CD34, DmelCG34403, photoreactivating enzyme activity, pigmented epithelium, IA5, LEF-1, Publication., Dmel_CG32005, Structural, Publication, parenchyma of lung, LEF1/TCF, lung, Functional, Classic Polyarteritis Nodosa, 3, stratum pigmentosa retinae, NUP96, neoplasm, epithelium, TCF/LEF, MOS3, deoxyribocyclobutadipyrimidine pyrimidine-lyase activity, PRECOCIOUS, Comparative Genomics, Tissue, pigmented retina, F23A5.3, Tcf-1, d-TCF, cTCF, DNA cyclobutane dipyrimidine photolyase activity, SUPPRESSOR OF AUXIN RESISTANCE 3, column, Clients, TCF/LEF1, heterogeneity, chimpanzees, 10X sequencing, polyarteritis, Pan, PAN, F23A5_3, PRE, Genomics, pulmo, Comparative, deoxyribonucleic cyclobutane dipyrimidine photolyase activity, Dmel_CG17964, lung parenchyma, 10x sequencing, Functional Genomics, LEF/TCF, Client, Cell, CD34, Dm Pan, MODIFIER OF SNC1, pan.dTCF, retinal pigment, PERIANTHIA, deoxyribonucleic photolyase activity, dipyrimidine photolyase (photosensitive), simple tissue, Tcf, TCF, Tcf/LEF, retinal pigment layer, neoplasms, Lef1, AU040960, periarteritis, RPE, LEF1, photolyase activity, F24J5.12, Classical Polyarteritis Nodosa, Panarteritis Nodosa, DTCF, DTcf, tcf, CG17964, l(4)102ABb, CG32005, F24J5_12, p. pigmentosa retinae, phr A photolyase activity, DNA-photoreactivating enzyme, pulmonary, Patient, Lef, Structural Genomics, Lungs, deoxyribonucleate pyrimidine dimer lyase (photosensitive), lef1, other neoplasm, dTCF, dTcffalseTranscriptional analysis of cells from lungsTo capture the full heterogeneity of the cellular types and states during HSPCs differentiation, haematopoietic progenitors will be obtained through column-enrichment of cells expressing CD34, a pan-progenitor marker for HSPCs. The samples from tumour and non-tumour lung tissue from different patients will be processed using the 10x Genomics platform. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/2020-07-16 15:33:08EGAS000010026499606EGAD00001005065EGAC00001000205